MK2 inhibition stabilizes wild-type and mutated p53 in glioblastoma cells and leads to different cellular responses

被引：0
|
作者：
Phoa, Athena Frances [1 ]
Recasens, Ariadna [1 ]
Munoz, Lenka [1 ]
机构：
[1] Univ Sydney, Sydney, NSW, Australia
来源：
MOLECULAR CANCER THERAPEUTICS | 2019年 / 18卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-19-A064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A064
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Wild-type p53 activates SAP expression in lymphoid cells
    Nagy, N
    Takahara, M
    Nishikawa, J
    Bourdon, JC
    Kis, LL
    Klein, G
    Klein, E
    ONCOGENE, 2004, 23 (53) : 8563 - 8570
  • [22] Inactivation of Wild-Type p53 by Asparagine Endopeptidase in Glioblastoma: An Opportunity to Target the "Undruggable"
    Manfredi, James J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (04): : 327 - 329
  • [23] WILD-TYPE p53 DRIVES A MESENCHYMAL PHENOTYPE AFTER TREATMENT OF PRIMARY GLIOBLASTOMA
    Li, Li
    Vemireddy, Vamsidhara
    Mashimo, Tomoyuki
    Huntington, Paula
    Mickey, Bruce
    Maher, Elizabeth
    Bachoo, Robert
    Piccirillo, Sara G. M.
    NEURO-ONCOLOGY, 2017, 19 : 258 - 259
  • [24] Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53
    Kraus, A
    Gross, MW
    Knuechel, R
    Münkel, K
    Neff, F
    Schlegel, J
    JOURNAL OF NEUROSURGERY, 2000, 93 (05) : 863 - 872
  • [25] Inhibition of MDM2 Promotes Antitumor Responses in p53 Wild-Type Cancer Cells through Their Interaction with the Immune and Stromal Microenvironment
    Wang, Hui Qin
    Mulford, Iain J.
    Sharp, Fiona
    Liang, Jinsheng
    Kurtulus, Sema
    Trabucco, Gina
    Quinn, David S.
    Longmire, Tyler A.
    Patel, Nidhi
    Patil, Roshani
    Shirley, Matthew D.
    Chen, Yan
    Wang, Hao
    Ruddy, David A.
    Fabre, Claire
    Williams, Juliet A.
    Hammerman, Peter S.
    Mataraza, Jennifer
    Platzer, Barbara
    Halilovic, Ensar
    CANCER RESEARCH, 2021, 81 (11) : 3079 - 3091
  • [26] Expression of different mutant p53 transgenes in neuroblastoma cells leads to different cellular responses to genotoxic agents
    Gangopadhyay, S
    Jalali, F
    Reda, D
    Peacock, J
    Bristow, RG
    Benchimol, S
    EXPERIMENTAL CELL RESEARCH, 2002, 275 (01) : 122 - 131
  • [27] Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities
    Ping Li
    Xiongxiong Liu
    Ting Zhao
    Feifei Li
    Qiqi Wang
    Pengcheng Zhang
    Ryoichi Hirayama
    Weiqiang Chen
    Xiaodong Jin
    Xiaogang Zheng
    Zhen Wang
    Qiang Li
    Cell Death Discovery, 7
  • [28] Comparable radiation sensitivity in p53 wild-type and p53 deficient tumor cells associated with different cell death modalities
    Li, Ping
    Liu, Xiongxiong
    Zhao, Ting
    Li, Feifei
    Wang, Qiqi
    Zhang, Pengcheng
    Hirayama, Ryoichi
    Chen, Weiqiang
    Jin, Xiaodong
    Zheng, Xiaogang
    Wang, Zhen
    Li, Qiang
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [29] MK-8242 IS ACTIVE IN PATIENTS WITH P53 WILD-TYPE ADVANCED SOLID TUMORS
    Wagner, A. J.
    Banerji, U.
    Mahipal, A.
    Somaiah, N.
    Hirsch, H.
    Fancourt, C.
    CANCER DISCOVERY, 2017, 7 (05) : 451 - 451
  • [30] ELEVATED LEVELS OF WILD-TYPE P53 INDUCED BY RADIOLABELING OF CELLS LEADS TO APOPTOSIS OR SUSTAINED GROWTH ARREST
    YEARGIN, J
    HAAS, M
    CURRENT BIOLOGY, 1995, 5 (04) : 423 - 431
12345